5-Amino-1MQ2020 Oct

ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development

Song Q, Chen Y, Wang J, et al.
Journal of hepatology

Key Finding

Showed that NNMT is upregulated during liver stress and directly contributes to fatty liver disease, supporting NNMT inhibition as a therapeutic strategy for liver health.

Key Takeaways

  • The NNMT enzyme gets overactivated when the liver is under stress, driving fat accumulation in the liver.
  • Blocking NNMT could help protect the liver from developing fatty liver disease.
  • This finding expands the potential benefits of NNMT inhibitors beyond weight management to liver health.

Study Breakdown

Fatty liver disease is an increasingly common condition with serious health consequences, and understanding the molecular pathways that drive it is essential for developing effective treatments. This study by Song, Chen, Wang, and colleagues, published in the Journal of Hepatology, investigated the role of NNMT in the development of alcohol-related fatty liver disease.

The researchers examined how endoplasmic reticulum (ER) stress — a form of cellular stress common in liver disease — affects NNMT expression and activity. They used both animal models and human liver tissue samples to determine whether NNMT upregulation contributes causally to fat accumulation in the liver.

The findings were clear: ER stress significantly upregulated NNMT expression in liver cells, and this elevated NNMT activity directly promoted hepatic fat accumulation. The study demonstrated a causal chain from cellular stress to NNMT overexpression to fatty liver development, establishing NNMT as a key mediator of liver fat metabolism gone wrong.

This research significantly expands our understanding of NNMT's role in metabolic health beyond adipose tissue. By showing that NNMT inhibition could protect the liver from stress-induced fat accumulation, the study supports the therapeutic potential of compounds like 5-Amino-1MQ for improving liver health alongside their established benefits for body composition and overall fat metabolism.

Read the full study on PubMed for complete methodology, data, and citations.

View Full Study on PubMed

PMID: 32389809

About 5-Amino-1MQ

A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that promotes fat cell metabolism and energy expenditure by blocking an enzyme linked to obesity and metabolic dysfunction.

Learn more about 5-Amino-1MQ

Interested in how this research applies to your health goals?

Consult Dr. Taylor

Disclaimer: This summary is for educational purposes only and is not medical advice. The study breakdown is a simplified overview of the published research. For complete methodology and data, refer to the original publication on PubMed. Always consult with a qualified healthcare provider before making medical decisions.